Abstract
Due to asymmetrical charge distribution of the mammalian high mobility group protein A2 (HMGA2), which makes HMGA2 bind to both cation- and anion-exchange columns, we developed a rapid procedure for purifying HMGA2 in the milligram range. This purification procedure greatly facilitated biophysical studies, which require large amounts of the protein.
Keywords: The mammalian high mobility group protein A2 (HMGA2), DNA binding protein, isothermal titration calorimetry, differential scanning calorimetry, nuclear magnetic resonance (NMR) Spectroscopy, intrinsically unstructured protein
Protein & Peptide Letters
Title: Large Scale Preparation of the Mammalian High Mobility Group Protein A2 for Biophysical Studies
Volume: 14 Issue: 1
Author(s): Tengjiao Cui, Suzanne Joynt, Victor Morillo, Maria Baez, Zhichun Hua, Xiaotang Wang and Fenfei Leng
Affiliation:
Keywords: The mammalian high mobility group protein A2 (HMGA2), DNA binding protein, isothermal titration calorimetry, differential scanning calorimetry, nuclear magnetic resonance (NMR) Spectroscopy, intrinsically unstructured protein
Abstract: Due to asymmetrical charge distribution of the mammalian high mobility group protein A2 (HMGA2), which makes HMGA2 bind to both cation- and anion-exchange columns, we developed a rapid procedure for purifying HMGA2 in the milligram range. This purification procedure greatly facilitated biophysical studies, which require large amounts of the protein.
Export Options
About this article
Cite this article as:
Cui Tengjiao, Joynt Suzanne, Morillo Victor, Baez Maria, Hua Zhichun, Wang Xiaotang and Leng Fenfei, Large Scale Preparation of the Mammalian High Mobility Group Protein A2 for Biophysical Studies, Protein & Peptide Letters 2007; 14 (1) . https://dx.doi.org/10.2174/092986607779117281
DOI https://dx.doi.org/10.2174/092986607779117281 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advancements in Adjuvanticity of Bioactive Inorganic and Organic Compounds
Endocrine, Metabolic & Immune Disorders - Drug Targets Screening of Antioxidant, Antimicrobial Activities and Chemical Contents of Edible Mushrooms Wildly Grown in the Black Sea Region of Turkey
Combinatorial Chemistry & High Throughput Screening Telomeres, Telomerase and Malignant Transformation
Current Molecular Medicine Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy The Genetic Basis of New Treatment Modalities in Melanoma
Current Drug Targets A Comprehensive Review on miR-200c, A Promising Cancer Biomarker with Therapeutic Potential
Current Drug Targets Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials Biology and Clinical Relevance of Mannose-Binding Lectin
Drug Design Reviews - Online (Discontinued) Lung Cancer May Increase Serum Procalcitonin Level
Infectious Disorders - Drug Targets Meet Our Editorial Board Member
Current Organic Synthesis RNA Silencing: Recent Developments on miRNAs
Recent Patents on DNA & Gene Sequences Formulation, Optimization, and <i>Ex-vivo</i> Evaluation of Novel Lipid Carriers for Enhanced Transdermal Delivery of Hydroquinone
Micro and Nanosystems Lung Cancer Stem Cells as a Target for Therapy
Anti-Cancer Agents in Medicinal Chemistry Dihidro-β-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania
Current Pharmaceutical Design 2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 1
Medicinal Chemistry In Vivo Imaging of Apoptosis in Cancer: Potentials and Drawbacks of Molecular Probes
Current Molecular Imaging (Discontinued) Emerging Role of Mucins in Epithelial to Mesenchymal Transition
Current Cancer Drug Targets Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer
Current Pharmaceutical Design A QSAR Study on a Series of Pyrrole Derivatives Acting as Lymphocyte- Specific Kinase (Lck) Inhibitors
Medicinal Chemistry Targeting Aurora Kinases in Cancer Treatment
Current Drug Targets